Systemic inflammation, as measured by the neutrophil/lymphocyte ratio, may have differential prognostic impact before and during treatment with fluorouracil, irinotecan and bevacizumab in metastatic colorectal cancer patients-Reference-Cited by-同舟云学术

Systemic inflammation, as measured by the neutrophil/lymphocyte ratio, may have differential prognostic impact before and during treatment with fluorouracil, irinotecan and bevacizumab in metastatic colorectal cancer patients

Published:2014-08-23 Issue:9 Volume:31 Page:
ISSN:1357-0560
Container-title:Medical Oncology
language:en
Short-container-title:Med Oncol

Author:

Formica Vincenzo,Luccchetti Jessica,Cunningham David,Smyth Elizabeth C.,Ferroni Patrizia,Nardecchia Antonella,Tesauro Manfredi,Cereda Vittore,Guadagni Fiorella,Roselli Mario

Publisher

Springer Science and Business Media LLC

Subject

Cancer Research,Oncology,Hematology,General Medicine

Link

http://link.springer.com/content/pdf/10.1007/s12032-014-0166-6.pdf

Reference39 articles.

1. Guthrie GJ, Roxburgh CS, Horgan PG, McMillan DC. Does interleukin-6 link explain the link between tumour necrosis, local and systemic inflammatory responses and outcome in patients with colorectal cancer? Cancer Treat Rev. 2013;39:89–96.

2. Dyson JK, Rutter MD. Colorectal cancer in inflammatory bowel disease: what is the real magnitude of the risk? World J Gastroenterol. 2012;18:3839–48.

3. Balkwill F, Mantovani A. Inflammation and cancer: back to Virchow? Lancet. 2001;357:539–45.

4. Coussens LM, Werb Z. Inflammation and cancer. Nature. 2002;420:860–7.

5. Aggarwal BB, Gehlot P. Inflammation and cancer: how friendly is the relationship for cancer patients? Curr Opin Pharmacol. 2009;9:351–69.

Cited by 47 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Neutrophil/Lymphocyte and Platelet/lymphocyte Ratios as Predictors of Patient Response to Bevacizumab in Iraqi Patients with Metastatic Colorectal Cancer;Al-Rafidain Journal of Medical Sciences ( ISSN 2789-3219 );2024-09-14

2. Change in the neutrophil‐lymphocyte ratio may predict early recurrence in operated bladder cancer;Asia-Pacific Journal of Clinical Oncology;2024-04-04

3. Should we consider Systemic Inflammatory Response Index (SIRI) as a new diagnostic marker for rectal cancer?;Discover Oncology;2024-02-21

4. Baseline and Longitudinal Neutrophil-to-Lymphocyte Ratio as Prognostic Factor for Metastatic Colorectal Cancer: A Secondary Analysis of the ITACa Randomized Trial;JCO Precision Oncology;2024-02

5. Elevated Baseline Neutrophil Count Correlates with Worse Outcomes in Patients with Muscle-Invasive Bladder Cancer Treated with Chemoradiation;Cancers;2023-03-21